Literature DB >> 7793138

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine.

P van der Ley1, J van der Biezen, J T Poolman.   

Abstract

Starting with Neisseria meningitidis strain H44/76, a set of strains was constructed for use in production of a multivalent outer membrane vesicle vaccine. The aim was to remove unwanted outer membrane components and at the same time to improve the range of protection. This was accomplished through transformation with plasmid constructs made in Escherichia coli and their homologous recombination into the meningococcal chromosome. Deletion of the cps locus resulted in loss of expression of the group B capsular polysaccharide as well as the lacto-N-neotetraose structure in lipopolysaccharide. Deletion of the porB gene abolished expression of the class 3 outer membrane protein. Additional copies of the porA gene, encoding the immunodominant class 1 outer membrane protein, were inserted into one of the opa genes and into the rmpM gene encoding the class 4 outer membrane protein. This construction was done with three sets of porA alleles, resulting in three trivalent strains, each of which expressed a different combination of class 1 epitopes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793138     DOI: 10.1016/0264-410x(95)98264-b

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  36 in total

1.  Multiple mechanisms of phase variation of PorA in Neisseria meningitidis.

Authors:  A van der Ende; C T Hopman; J Dankert
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.

Authors:  E R van der Voort; P van der Ley; J van der Biezen; S George; O Tunnela; H van Dijken; B Kuipers; J Poolman
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Working mechanism of immunoglobulin A1 (IgA1) protease: cleavage of IgA1 antibody to Neisseria meningitidis PorA requires de novo synthesis of IgA1 Protease.

Authors:  Gestur Vidarsson; Natasja Overbeeke; Annette M Stemerding; Germie van den Dobbelsteen; Peter van Ulsen; Peter van der Ley; Mogens Kilian; Jan G J van de Winkel
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.

Authors:  Peter T Beernink; Jo Anne Welsch; Lee H Harrison; Arunas Leipus; Sheldon L Kaplan; Dan M Granoff
Journal:  J Infect Dis       Date:  2007-04-05       Impact factor: 5.226

5.  Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic.

Authors:  K H Dyet; D R Martin
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

6.  The Omp85 protein of Neisseria meningitidis is required for lipid export to the outer membrane.

Authors:  Stéphanie Genevrois; Liana Steeghs; Paul Roholl; Jean-Jacques Letesson; Peter van der Ley
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

7.  Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.

Authors:  D Martin; N Cadieux; J Hamel; B R Brodeur
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

8.  Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response.

Authors:  Afshin Zariri; Joep Beskers; Bas van de Waterbeemd; Hendrik Jan Hamstra; Tim H E Bindels; Elly van Riet; Jos P M van Putten; Peter van der Ley
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 9.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

10.  Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB.

Authors:  Julia S Bennett; Martin J Callaghan; Jeremy P Derrick; Martin C J Maiden
Journal:  Microbiology (Reading)       Date:  2008-05       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.